Oruka Therapeutics’ (ORKA) Outperform Rating Reiterated at Wedbush
Wedbush reissued their outperform rating on shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) in a research note issued to investors on Thursday morning,Benzinga reports. Wedbush currently has a $40.00 target price on the stock. Wedbush also issued estimates for Oruka Therapeutics’ FY2029 earnings at ($4.14) EPS. A number of other analysts have also issued […]
Wedbush reissued their outperform rating on shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) in a research note issued to investors on Thursday morning,Benzinga reports. Wedbush currently has a $40.00 target price on the stock. Wedbush also issued estimates for Oruka Therapeutics’ FY2029 earnings at ($4.14) EPS. A number of other analysts have also issued […]
